<Suppliers Price>

1,3-Difluoro-2-nitrobenzene

Names

[ CAS No. ]:
19064-24-5

[ Name ]:
1,3-Difluoro-2-nitrobenzene

[Synonym ]:
Benzene, 1,3-difluoro-2-nitro-
1,3-Difluoro-2-nitrobenzene
1,3-difluoro-2-nitro-benzene
2,6-Difluoronitrobenzene
2,6-fluoronitrobenzene
MFCD00192035
2,5-DICHLOROPHENYL ETHANOL
2,6-difluoro-nitrobenzene
2,6-difluoro-1-nitrobenzene
EINECS 242-793-8
WNR BF FF

Chemical & Physical Properties

[ Density]:
1.5±0.1 g/cm3

[ Boiling Point ]:
220.1±20.0 °C at 760 mmHg

[ Melting Point ]:
ºC

[ Molecular Formula ]:
C6H3F2NO2

[ Molecular Weight ]:
159.090

[ Flash Point ]:
94.1±10.1 °C

[ Exact Mass ]:
159.013184

[ PSA ]:
45.82000

[ LogP ]:
1.47

[ Vapour Pressure ]:
0.2±0.4 mmHg at 25°C

[ Index of Refraction ]:
1.510

MSDS

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H315-H319-H335

[ Precautionary Statements ]:
P261-P305 + P351 + P338

[ Personal Protective Equipment ]:
Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges

[ Hazard Codes ]:
Xi:Irritant;

[ Risk Phrases ]:
R10;R36/37/38

[ Safety Phrases ]:
S16-S26-S36

[ WGK Germany ]:
3

[ HS Code ]:
2904909090

Synthetic Route

Precursor & DownStream

Customs

[ HS Code ]: 2904909090

[ Summary ]:
HS:2904909090 sulphonated, nitrated or nitrosated derivatives of hydrocarbons, whether or not halogenated VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:5.5% General tariff:30.0%

Articles

Molecular structure, conformation, and potential to internal rotation of 2,6- and 3,5-difluoronitrobenzene studied by gas-phase electron diffraction and quantum chemical calculations.

J. Phys. Chem. A 112(22) , 5002-9, (2008)

3,5-Difluoronitrobenzene (3,5-DFNB) and 2,6-difluoronitrobenzene (2,6-DFNB) have been studied by gas-phase electron diffraction (GED), MP2 ab initio, and by B3LYP density functional calculations. Refi...

Secondary amines containing one aromatic nitro group: preparation, nitrosation, sustained nitric oxide release, and the synergistic effects of released nitric oxide and an arginase inhibitor on vascular smooth muscle cell proliferation.

Bioorg. Med. Chem. 21(5) , 1123-35, (2013)

Atherosclerosis, a leading cause of death worldwide, is associated with the excessive proliferation of vascular smooth muscle cells. Nitrogen monoxide, more commonly known as nitric oxide, inhibits th...


More Articles


Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.